Clinical Trial Update: A Phase I Trial of Af-001 in Patients With Differentiated Thyroid Cancer [Phase 1]

View source ↗

Summary

A Phase I study of Af-001 for differentiated thyroid cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Cancer

Drugs mentioned

• Af-001

Snippet

Sponsor: Alpha Fusion Inc. | Conditions: DTC - Differentiated Thyroid Cancer | Phase 1 | Status: RECRUITING